Farmers & Merchants Investments Inc’s Catalyst Pharmaceutical CPRX Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11K	Hold	67	–	–	﹤0.01%	1272
2026 Q1	$1.66K	Sell	67 -8	-11%	-$191	﹤0.01%	1314
2025 Q4	$1.75K	Hold	75	–	–	﹤0.01%	1276
2025 Q3	$1.48K	Hold	75	–	–	﹤0.01%	1349
2025 Q2	$1.63K	Hold	75	–	–	﹤0.01%	1297
2025 Q1	$1.82K	Hold	75	–	–	﹤0.01%	1257
2024 Q4	$1.56K	Hold	75	–	–	﹤0.01%	1291
2024 Q3	$1.49K	Hold	75	–	–	﹤0.01%	1329
2024 Q2	$1.16K	Hold	75	–	–	﹤0.01%	1406
2024 Q1	$1.2K	Hold	75	–	–	﹤0.01%	1368
2023 Q4	$1.26K	Hold	75	–	–	﹤0.01%	1350
2023 Q3	$877	Hold	75	–	–	﹤0.01%	1431
2023 Q2	$1.01K	Hold	75	–	–	﹤0.01%	1394
2023 Q1	$1.24K	Hold	75	–	–	﹤0.01%	1285
2022 Q4	$1.4K	Hold	75	–	–	﹤0.01%	1241
2022 Q3	$1K	Buy	+75	New	+$889	﹤0.01%	1210

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

GCM

Gables Capital Management Miami, Florida $277M AUM 41.87% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Farmers & Merchants Investments Inc's CPRX Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 67 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

Farmers & Merchants Investments Inc first reported a position in CPRX in Q3 2022 and has held it in 16 quarters since. 183 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Farmers & Merchants Investments Inc held 67 shares of Catalyst Pharmaceutical worth $2.11K as of Q2 2026.
Farmers & Merchants Investments Inc left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
Catalyst Pharmaceutical made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1272 holding.
Farmers & Merchants Investments Inc first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
183 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.